Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
http://doi.org/10.25358/openscience-7840
Autoren: | Krusche, Benjamin Arend, Joachim Efferth, Thomas |
Titel: | Synergistic inhibition of angiogenesis by artesunate and captopril in vitro and in vivo |
Online-Publikationsdatum: | 5-Okt-2022 |
Erscheinungsdatum: | 2013 |
Sprache des Dokuments: | Englisch |
Zusammenfassung/Abstract: | Inhibition of angiogenesis represents one major strategy of cancer chemotherapy. In the present investigation, we investigated the synergism of artesunate and captopril to inhibit angiogenesis. Artesunate is an antimalarial derivative of artemisinin from the Chinese medicinal plant, Artemisia annua L., which also reveals profound anticancer activity in vitro and in vivo. Captopril is an angiotensin I-converting (ACE) inhibitor, which is well established in Western academic medicine. Both compounds inhibited migration of human umbilical vein endothelial cells (HUVECs) in vitro. The combination of both drugs resulted in synergistically inhibited migration. Whereas artesunate inhibited HUVEC growth in the XTT assay, captopril did not, indicating independent modes of action. We established a chorioallantoic membrane (CAM) assay of quail embryos (Coturnix coturnix L.) and a computer-based evaluation routine for quantitative studies on vascularization processes in vivo. Artesunate and captopril inhibited blood vessel formation and growth. For the first time, we demonstrated that both drugs revealed synergistic effects when combined. These results may also have clinical impact, since cardiovascular diseases and cancer frequently occur together in older cancer patients. Therefore, comorbid patients may take advantage, if they take captopril to treat cardiovascular symptoms and artesunate to treat cancer. |
DDC-Sachgruppe: | 570 Biowissenschaften 570 Life sciences |
Veröffentlichende Institution: | Johannes Gutenberg-Universität Mainz |
Organisationseinheit: | FB 09 Chemie, Pharmazie u. Geowissensch. |
Veröffentlichungsort: | Mainz |
ROR: | https://ror.org/023b0x485 |
DOI: | http://doi.org/10.25358/openscience-7840 |
Version: | Published version |
Publikationstyp: | Zeitschriftenaufsatz |
Nutzungsrechte: | CC BY |
Informationen zu den Nutzungsrechten: | https://creativecommons.org/licenses/by/3.0/ |
Zeitschrift: | Evidence-based complementary and alternative medicine 2013 |
Seitenzahl oder Artikelnummer: | Art. 454783 |
Verlag: | Hindawi |
Verlagsort: | New York, NY |
Erscheinungsdatum: | 2013 |
ISSN: | 1741-4288 1741-427X |
URL der Originalveröffentlichung: | http://dx.doi.org/10.1155/2013/454783 |
DOI der Originalveröffentlichung: | 10.1155/2013/454783 |
Enthalten in den Sammlungen: | DFG-OA-Publizieren (2012 - 2017) |
Dateien zu dieser Ressource:
Datei | Beschreibung | Größe | Format | ||
---|---|---|---|---|---|
synergistic_inhibition_of_ang-20221005103458805.pdf | 721.22 kB | Adobe PDF | Öffnen/Anzeigen |